Sector News

Stryker Corporation to create hundreds of jobs at new Irish base

March 30, 2015
Life sciences
The Stryker Corporation, one of the world’s leading medical technology firms, is to create hundreds of new jobs with a multi-million euro investment in Cork.
 
The company is to formally announce plans to build a global centre of excellence at Carrigtwohill this week.
 
The firm currently employs around 1,200 people in Ireland including 700 at two IDA sites in Carrigtwohill with a further 500 employed at a factory in Raheen, Limerick.
 
The Irish Examiner reports that the new plant is expected to be built before the end of the year and that it will create hundreds of jobs. Part of the remit of the new plant will be to build hip and knee replacements with 3D laser printing technology.
 
By Paul O’Donoghue
 

comments closed

Related News

October 23, 2021

Novo Nordisk teams with CVS Health on obesity support program ahead of Wegovy DTC launch

Life sciences

As Novo Nordisk gears up to disrupt the obesity market with its newly approved weight-loss drug Wegovy, it is teaming with retail pharmacy giant CVS Health on a new education and nutrition coaching program for people taking anti-obesity meds.

October 23, 2021

GSK-backed Atreca inks license with Gates Medical Research Institute for malaria monoclonal antibody

Life sciences

The terms of the deal were undisclosed, but Atreca received $6 million from the Gates Foundation in 2012 to discover potential treatments for malaria, tuberculosis and HIV. The foundation has also given grant money to other biopharmas exploring malaria treatments, including Exscientia, which secured $4.2 million last year for such work.

October 23, 2021

A record number of biotechs are going public. Here’s how they’re performing.

Life sciences

At the start of the last decade, the IPO markets weren’t receptive to biotech companies. But by 2013, public investment was pouring into the industry, drawn by scientific advances and boosted by the newfound interest of a broader range of investors. Ever since, biotechs and their backers have ridden a multi-year boom. Keep track of them as they happen with this database.

Send this to a friend